or
forgot password
  • cancer clinical trials in glen burnie, MD

  • Efficacy and Safety of Zoledronic Acid ( Every 4 Weeks vs. Every 12 Weeks) in Patients With Documented Bone Metastases From Bone Cancer
    Chesapeake Oncology Hematology Associates P.A.
    Glen Burnie, Maryland 21061
    Breast Cancer
    Radiation Therapy in Treating Patients With Stage II Prostate Cancer
    Tate Cancer Center at Baltimore Washington Medical Center
    Glen Burnie, Maryland 21061
    Prostate Cancer
    Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors
    Tate Cancer Center at Baltimore Washington Medical Center
    Glen Burnie, Maryland 21061
    Cognitive/Functional Effects, Metastatic Cancer, Neurotoxicity, Unspecified Adult Solid Tumor, Protocol Specific
    Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
    Tate Cancer Center at Baltimore Washington Medical Center
    Glen Burnie, Maryland 21061
    Prostate Cancer, Sexual Dysfunction
    Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
    Tate Cancer Center at Baltimore Washington Medical Center
    Glen Burnie, Maryland 21061
    Prostate Cancer
    Preoperative Accelerated Partial Breast Irradiation (APBI) for Women With Stage I and Select IIA Breast Cancer
    Baltimore Washington Medical Center
    Glen Burnie, Maryland 21061
    Breast Cancer
    Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
    Tate Cancer Center at Baltimore Washington Medical Center
    Glen Burnie, Maryland 21061
    Breast Cancer
    Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
    Tate Cancer Center at Baltimore Washington Medical Center
    Glen Burnie, Maryland 21061
    Prostate Cancer
    Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Chesapeake Oncology Hematology Associates (Tate Center)
    Glen Burnie, Maryland 21061
    Carcinoma, Non-Small Cell Lung
    Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
    Chesapeake Oncology Hematology Associates (Tate Center)
    Glen Burnie, Maryland 21061
    Carcinoma, Non-Small-Cell Lung, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary
    Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
    Chesapeake Oncology Hematology Associates, PA
    Glen Burnie, Maryland 21061
    Cancer Cachexia